Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 Wisconsin Avenue
Bethesda, MD 20889
Education & Training
- National Capital ConsortiumFellowship, Allergy and Immunology, 2005 - 2007
- National Capital ConsortiumResidency, Internal Medicine, 2002 - 2005
- University of Rochester School of Medicine and DentistryClass of 2002
Certifications & Licensure
- VA State Medical License 2003 - 2026
- DC State Medical License 2007 - 2016
- American Board of Allergy and Immunology Allergy & Immunology
Publications & Presentations
PubMed
- 23 citationsFDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer.Melanie Royce, Christy L Osgood, Anup K Amatya, Mallorie H Fiero, C J George Chang
Clinical Cancer Research. 2022-04-14 - 55 citationsAssociation of BCG Vaccination in Childhood With Subsequent Cancer Diagnoses: A 60-Year Follow-up of a Clinical Trial.Nicholas Usher, Suyoung Chang, Robin S. Howard, Adriana Martinez, Lee H. Harrison
JAMA Network Open. 2019-09-04 - 6 citationsUrticarial vasculitis.Suyoung Chang, Warner Carr
Allergy and Asthma Proceedings. 2007-03-30
Journal Articles
- FDA Approval Summary: Margetuximab plus chemotherapy for advanced or metastatic HER2-positive breast cancerMelanie Royce, Christy L. Osgood, Anup K Amatya, Mallorie H. Fiero, C.J. George Chang, Tiffany K. Ricks, Krithika A. Shetty, Jeffrey Kraft, Junshan Qiu, Pengfei Song, ..., Clinical Cancer Research
Press Mentions
- FDA Mulls Parameters for Allergy TherapiesJune 5th, 2021
- Fullfillment in the USPHSJune 5th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: